If you’re looking for stocks that have the potential to rise in value, then buying shares that are trading at low prices is one way to help improve those odds. With a low price, a stock can become more appealing to investors to own, as affordability is not an issue. It’s one of the reasons companies choose to use stock…
Read More
Leading cannabis firm Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stunned the market on Wednesday last week after announcing the immediate departure of its Co-CEO and Board Chairman Bruce Linton and his ouster from the board. Is the stock a buy after this fundamental leadership change? A growing number of institutional investors in a growth stock can be a great thing, and we…
Read More
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) recently announced CEO Bruce Linton would be stepping down from his post. The news came after Constellation Brands Inc (NYSE:STZ) execs said they were “not pleased” with Canopy’s results. Constellation, with a near-majority stake in Canopy, has significant influence on the board and may well have pushed for the decision to remove Linton. Shortly after Linton’s departure…
Read More
The cannabis industry is an exciting one to invest in given all the growth potential it possesses. However, there’s also a lot of risk, and investors often have to pay big premiums to own stocks that haven’t generated much in sales. That’s why I’ve avoided the industry, as there are better, more value-oriented investments to make out there. However, there…
Read More
Shares of HEXO (TSX:HEXO) are down nearly 40% from the April high, and investors who missed the big rally to start the year are wondering if the pullback is an opportunity to start a new position in the popular marijuana stock. Let’s take a look at the current situation to see if HEXO deserves to be on your buy list.…
Read More
Aphria (TSX:APHA)(NYSE:APHA) stock tanked after a controversial research report from a hedge fund accused the company of being a shell with a marijuana business on the side. Over the last year, Aphria’s stock has lost 16% compared to the outsized gains of its peers, including industry leader Canopy Growth surging by 63% and Cronos Group gaining a whopping 175%. This…
Read More
If you’re under 40 years old, you likely can take more risk than a retiree. This is a great advantage given that you can invest with a long-term mindset, with decades-long horizons. Just because a stock has more risk, however, doesn’t mean there’s automatically more upside. Paying attention to the price you pay is just as important as managing your…
Read More
It’s time to start getting picky about pot stocks. The dust certainly hasn’t settled yet, though there has been a bit of mellowing out around the marijuana sector. After record highs came some lows, and now investors need to start getting serious about where certain stocks are headed. Hopefully, it’s in an upward direction. But that means these stocks have…
Read More
It seems like the cannabis sector is going through a bit of a dry spell of late. It’s not that stocks have started to do badly, but we’re not seeing the gangbuster days of last summer either. It can be hard to judge whether to buy, hold, or sell certain cannabis stocks. But of these three, there are two I…
Read More